TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director July 28, 1995